Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 467
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT03432286 REBUILD-1 — A Study of Galcanezumab (LY2951742) in Participants 6 to 17… |
Galcanezumab | Migraine | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Eli Lilly and Company | United States, Denmark, Germany, India, Italy, Japan,… | 2018-03-14 → 2026-11 | Ouvrir |
| NCT07313800 EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Em… |
TEMMA Endovascular Treatment | Migraine | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Cortex Neurovascular | United States · Cortex Neurovascular / TRA Union, Tac… | 2026-03-01 → 2028-03-01 | Ouvrir |
| NCT03461874 ACTMigraine — ACT Therapy for HF Migraine |
Pharmacological prophylaxis | Migraine | Non applicable | COMPLETED | En attente / non publié | Fondazione I.R.C.C.S. Istituto Ne… | Italy · Fondazione IRCCS Istituto Neurologico C. Best… | 2018-03-15 → 2022-12-31 | Ouvrir |
| NCT05003362 ACT for High Frequency Migraine; A Virtual Mindfulness Intervention |
ACT for High Frequency Migraine; … | Migraine | Non applicable | COMPLETED | En attente / non publié | Brigham and Women's Hospital | United States · Brigham and Womens Hospital, Boston, … | 2020-10-25 → 2021-11-23 | Ouvrir |
| NCT04252742 EMBRACE — Erenumab - Comprehensive Assessment of Efficacy in (High-Freq… |
Erenumab | Migraine | Phase 4 | COMPLETED | En attente / non publié | Amgen | United States, Bulgaria, Czechia, Hungary, Italy, Pol… | 2020-09-15 → 2023-10-26 | Ouvrir |
| NCT07508449 EXEMIG/01 — EXErcise in MIGraine |
EXEMIG/01 — EXErcise in MIGraine | Migraine | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Centro Universitario Ricerca Inte… | Italy · Centro Cefalee c/o Ospedale Santa Maria della… | 2025-02-03 → 2027-02-03 | Ouvrir |
| NCT06617832 Trial Designs for Evaluating Migraine Treatment |
Active drug for acute migraine tr… | Migraine | Non applicable | RECRUITING | En attente / non publié | University of Aarhus | Denmark · Department of Neurology, Aarhus University … | 2024-11-13 → 2028-09 | Ouvrir |
| NCT07559565 MechSens_Migra — Migraine is Associated With Altered Mechanical Pain Se… |
MechSens_Migra — Migraine is Asso… | Migraine | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Bernhard Taxer | Austria · Universitätsklinik für Neurologie, neurolog… | 2026-06-01 → 2026-11-30 | Ouvrir |
| NCT07496034 GTSEM — Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migrai… |
Gou-Teng-San | Migraine | Phase 3 | RECRUITING | En attente / non publié | Tsai, Chueh-Yi, MD | Taiwan · Chung Shan Medical University Hospital, Taic… | 2025-07-01 → 2026-12-31 | Ouvrir |
| NCT05861427 JPN PIVOTAL — Study of Oral Atogepant Tablets to Assess Change in Disea… |
Atogepant | Migraine | Phase 3 | COMPLETED | En attente / non publié | AbbVie | Japan · Atago Hospital /ID# 245818, Kochi, Japan | Ch… | 2023-07-12 → 2025-03-01 | Ouvrir |
| NCT05734625 Efficacy of Nerve Blocks for Episodic Migraine |
Bupivacaine HCl 0.5% Injectable S… | Migraine | Phase 2 | RECRUITING | En attente / non publié | Mayo Clinic | United States · Mayo Clinic in Rochester, Rochester, … | 2023-07-10 → 2027-07 | Ouvrir |
| NCT07661888 Neurofeedback for Episodic Migraine |
Neurofeedback for Episodic Migrai… | Migraine | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of Salamanca | Spain · University Hospital of Salamanca, Salamanca, … | 2026-11-15 → 2027-12-31 | Ouvrir |
| NCT04458857 A Study to Test if Fremanezumab is Effective in Preventing Episodic Mig… |
Fremanezumab | Migraine | Phase 3 | COMPLETED | En attente / non publié | Teva Branded Pharmaceutical Produ… | United States, Canada, Finland, Germany, Israel, Ital… | 2020-07-15 → 2024-03-13 | Ouvrir |
| NCT07018700 MINT-E — A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® In… |
Xeomin | Migraine | Phase 3 | RECRUITING | En attente / non publié | Merz Therapeutics GmbH | United States, Austria, Canada, Czechia, Denmark, Fra… | 2025-08-21 → 2027-10 | Ouvrir |
| NCT06229834 Chiropractic Care for Episodic Migraine |
Chiropractic Care | Migraine | Non applicable | RECRUITING | En attente / non publié | Brigham and Women's Hospital | United States · Osher Center for Integrative Health, … | 2025-03-22 → 2027-04-30 | Ouvrir |
| NCT07694063 MIGRANE-YOGA — Online Hatha Yoga Program as an Add-On Therapy for Episo… |
MIGRANE-YOGA — Online Hatha Yoga … | Migraine | Non applicable | RECRUITING | En attente / non publié | University of Seville | Spain · University Hospital Virgen del Rocio, Seville… | 2026-01-27 → 2026-10-30 | Ouvrir |
| NCT06248671 EStatinMig — Prophylactic Treatment With Atorvastatin for Episodic Migr… |
Atorvastatin 40mg | Migraine | Phase 2 | RECRUITING | En attente / non publié | St. Olavs Hospital | Norway · Haukeland University Hospital, Bergen, Norwa… | 2024-05-01 → 2029-02-28 | Ouvrir |
| NCT05897320 PROSPECT-1 — A Study of Eptinezumab in Pediatric Participants With Epis… |
Eptinezumab | Migraine | Phase 3 | RECRUITING | En attente / non publié | H. Lundbeck A/S | United States, Argentina, Canada, Italy, Mexico, Pola… | 2023-06-08 → 2027-08-31 | Ouvrir |
| NCT05711394 A Study to Assess the Adverse Events and Change in Disease Activity of … |
Atogepant | Migraine | Phase 3 | RECRUITING | En attente / non publié | AbbVie | United States, Belgium, Canada, Denmark, France, Hung… | 2023-05-01 → 2028-05 | Ouvrir |
| NCT03836040 OASIS(EM) — Efficacy and Safety of Erenumab in Pediatric Participants W… |
Erenumab Dose 1 | Migraine | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Amgen | United States, Belgium, Canada, Colombia, Finland, Ge… | 2019-07-19 → 2026-11-19 | Ouvrir |
| NCT07061847 Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debili… |
Lidocaine (drug) | Migraine | Phase 2 | RECRUITING | En attente / non publié | Daniel A Tonetti, MD | United States · Neuroscience Institute at Great Neck,… | 2025-03-10 → 2027-06-30 | Ouvrir |
| NCT07617441 SIGMA — The Neuroanatomical and Psychological Correlates of Suggestibil… |
SIGMA — The Neuroanatomical and P… | Migraine | À vérifier | RECRUITING | En attente / non publié | Istituto per la Ricerca e l'Innov… | Italy · Renato Dulbecco University Hospital, Catanzar… | 2026-07-01 → 2029-05 | Ouvrir |
| NCT07598045 RHUMIL-6 — Efficacy of Anti-IL-6 Treatments on Migraine in Patients Tre… |
RHUMIL-6 — Efficacy of Anti-IL-6 … | Migraine | À vérifier | NOT_YET_RECRUITING | En attente / non publié | University Hospital, Clermont-Fer… | France · CHU Clermont-Ferrand, Clermont-Ferrand, Fran… | 2026-05-26 → 2027-05-26 | Ouvrir |
| NCT07633522 Fire Needling Plus Filiform Needling for Chronic Migraine With Comorbid… |
filiform needling | Migraine | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Beijing Hospital of Traditional C… | China · Beijing Hospital of Traditional Chinese Medic… | 2026-08 → 2028-12 | Ouvrir |
| NCT05306899 KetHead — Multi-center RCT of IV Ketamine Efficacy and Safety in Chroni… |
Ketamine | Migraine | Phase 3 | RECRUITING | En attente / non publié | Emory University | Canada · Toronto Western Hospital, Toronto, Canada | … | 2022-06-01 → 2027-06-01 | Ouvrir |